Understanding how the nervous system affects immunity to C. difficile infections

Nervous system control of immunity to C. difficile

NIH-funded research University of Oklahoma Hlth Sciences Ctr · NIH-10892834

This study is looking at how the nervous system affects the immune response to Clostridioides difficile infections, which can cause serious problems in hospitals, to find better ways to help patients who keep getting these infections.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Oklahoma Hlth Sciences Ctr NIH-funded
Lab location1 site (Oklahoma City, United States)
Project IDNIH-10892834 on NIH RePORTER

What this research studies

This research investigates the relationship between the nervous system and the immune response to Clostridioides difficile infections, which are a leading cause of hospital-acquired infections. The study aims to uncover how C. difficile evades the immune system and why some patients experience recurrent infections. By examining the role of sensory and adrenergic nerves in the gut and lymphoid organs, the researchers hope to identify new treatment strategies that enhance immune responses against this pathogen. Patients may benefit from insights that could lead to improved therapies and prevention methods for C. difficile infections.

Who could benefit from this research

Good fit: Ideal candidates for this research include patients who have experienced recurrent C. difficile infections or are at high risk due to factors like antibiotic use or inflammatory bowel disease.

Not a fit: Patients who have never had a C. difficile infection or those with unrelated gastrointestinal conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance the immune response to C. difficile, reducing the incidence of recurrent infections.

How similar studies have performed: While the specific approach of linking nervous system function to immunity in C. difficile is novel, there is growing evidence that similar mechanisms have been successful in other infectious diseases.

Where this research is happening

Oklahoma City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.